Home Cart Sign in  
Chemical Structure| 62596-29-6 Chemical Structure| 62596-29-6

Structure of Morusin
CAS No.: 62596-29-6

Chemical Structure| 62596-29-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Morusin shows suppression of NFκB and STAT3 in many cancer cell lines including HT-29, A549, MCF-7, and MDA-MB-231. It is a flavonoid purified from the root bark of morus alba L. with antitumor activity.

Synonyms: Mulberrochromene; NSC 649220

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Morusin

CAS No. :62596-29-6
Formula : C25H24O6
M.W : 420.45
SMILES Code : O=C1C2=C(O)C=C3C(C=CC(C)(C)O3)=C2OC(C4=CC=C(O)C=C4O)=C1C/C=C(C)\C
Synonyms :
Mulberrochromene; NSC 649220
MDL No. :MFCD09953814
InChI Key :XFFOMNJIDRDDLQ-UHFFFAOYSA-N
Pubchem ID :5281671

Safety of Morusin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Morusin

JAK-STAT
pyroptosis

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Human breast cancer cells (MDA-MB-231) 1, 2, 4, 6, 8 μg/ml 1, 2, 3, 4, 5 days Test the cytotoxicity of Morusin on MDA-MB-231 cells, IC50 was 3.86 μg/ml PMC4634597
Human breast cancer cells (MCF-7) 1, 2, 4, 6, 8 μg/ml 1, 2, 3, 4, 5 days Test the cytotoxicity of Morusin on MCF-7 cells, IC50 was 2.71 μg/ml PMC4634597
Murine breast cancer cells (EMT6) 1, 2, 4, 6, 8 μg/ml 1, 2, 3, 4, 5 days Test the cytotoxicity of Morusin on EMT6 cells, IC50 was 1.87 μg/ml PMC4634597
Murine breast cancer cells (4T1) 1, 2, 4, 6, 8 μg/ml 1, 2, 3, 4, 5 days Test the cytotoxicity of Morusin on 4T1 cells, IC50 was 2.03 μg/ml PMC4634597
Human normal mammary epithelial cells (MCF-10A) 1, 2, 4, 6, 8 μg/ml 1, 2, 3, 4, 5 days Test the cytotoxicity of Morusin on normal mammary epithelial cells, IC50 was 9.48 μg/ml PMC4634597
Aortic valve interstitial cells (VICs) 1 μM 21 days To evaluate the long-term effect of Morusin on osteogenic differentiation of VICs. Results showed Morusin significantly reduced calcific nodule formation. PMC11132047
Aortic valve interstitial cells (VICs) 1 μM 7 days To evaluate the long-term effect of Morusin on osteogenic differentiation of VICs. Results showed Morusin significantly reduced calcific nodule formation. PMC11132047
Bone marrow mesenchymal stem cells (BMSCs) 2.5-10 μM 3, 5, 7, 14 days Promoted proliferation and osteogenic differentiation of BMSCs, with 10 μM Morusin showing the strongest effect PMC7953707
FH c cells (normal fetal colonic mucosa cells) 9.1, 18.2, 36.4 µM 24, 48, 72 hours Morusin did not significantly affect the proliferation of normal colonic mucosa cells FH c. PMC7891835
HCT116 human colorectal cancer cells 9.1, 18.2, 36.4 µM 24, 48, 72 hours Morusin significantly inhibited the proliferation of HCT116 sphere cells in a concentration- and time-dependent manner. PMC7891835
SW480 cells 0, 2.5, 5 μM 24 hours To investigate the activation of PEPT1 transcription by DAC, results showed DAC activated PEPT1 transcription in a dose-dependent manner. PMC8395021
HCT116 cells 0, 2.5, 5 μM 24 hours To evaluate the effect of terbinafine on CRC cell viability, results showed that terbinafine significantly reduced the viability of HCT116 cells. PMC8395021
SW480 cells 0, 2.5, 5, 10 μM 24 hours To investigate the activation of PEPT1 transcription by DAC, results showed DAC activated PEPT1 transcription in a dose-dependent manner. PMC8395021
HCT116 cells 0, 2.5, 5, 10 μM 24 hours To evaluate the effect of terbinafine on CRC cell viability, results showed that terbinafine significantly reduced the viability of HCT116 cells. PMC8395021
HeLa cells 1-10 μM 12 hours To evaluate the ability of BSA–RuII(CO)2 complex to release CO in HeLa cells, results showed a significant increase in intracellular fluorescence indicating CO release. PMC9886792
RAW264.7 macrophages 9.87 ± 0.59 μM 24 hours Evaluate the inhibitory effect of Morusin on NO production in RAW264.7 macrophages, showing that Morusin exhibited stronger anti-NO activity than the positive control quercetin. PMC9686747
Ruminal epithelial cells (RECs) 25 µg/mL and 50 µg/mL 12 hours Morusin exerted anti-inflammatory effects in a concentration-dependent manner, with 50 µg/mL Morusin significantly downregulating the gene expression of TNF-α, CD40, IL-6, and CCL20 in RECs PMC9695078

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice Subcutaneous xenograft model of human breast cancer MCF-7 cells Intraperitoneal injection 5, 10 mg/kg Three times weekly for 4 weeks Test the tumor inhibitory effect of Morusin on MCF-7 xenografts, tumor inhibitory rates were 46.5% and 64.1% at doses of 5 mg/kg and 10 mg/kg, respectively PMC4634597
ApoE−/− mice High-fat Western diet-induced aortic valve calcification model Gavage 40 mg/kg Twice a week for 24 weeks To evaluate the therapeutic effect of Morusin on aortic valve calcification. Results showed Morusin significantly alleviated high-fat diet-induced aortic valve calcification and reduced ROS levels. PMC11132047
Wistar rats Ovariectomy-induced osteoporosis model Intragastric administration 40 mg/kg Every 5 days for 4 weeks Morusin attenuated bone loss in OVX rats, increased trabecular number and bone mass indexes PMC7953707
Caenorhabditis elegans Wild-type N2 and akt-1(ok525) and akt-2(ok393) mutants NGM media or E. coli OP50-1 feeding 120 μM Starting from the L4 stage and continued throughout lifespan Extended mean lifespan, increased reproduction, without affecting health metrics (e.g., pharyngeal pumping rate) PMC9886792

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.38mL

0.48mL

0.24mL

11.89mL

2.38mL

1.19mL

23.78mL

4.76mL

2.38mL

References

 

Historical Records

Categories